GVHD is the medical shorthand for Graft Versus Host Disease.
Today a quick, non-geeky look at the phenomenon of GVHD, and how it differs from Transplanted Organ Rejection as seen in the previous cartoons noir post.(click here )
For those of you just joining us, the procedure I have undergone here at Duke Med is technically an Allogenic Myleoablative Stem Cell Transplant or Bone Marrow Transplant.
Allogenic: Taken from a donor (as opposed to autogenic, where they take your own cells out, hit you with some chemo, then put your own cells back in, or the syngeneic using stem cells donated by an identical twin)
Myleoablative: High-dose chemotherapy designed to completely wipe out the diseased blood-forming cells in the bone marrow. This chemo can cause side effects, often severe.
SCT: Stem Cell Transplant
BMT: Bone Marrow Transplant, often used interchangeably with SCT
As part of this I volunteered to participate in a clinical trial, A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients with Myelodysplastic Syndrome or Acute Myeloid Leukemia. The regimen intensity refers to the pre-transplant chemo. I was randomized into the High Dose group, read about it in this post from March 27th. .
|
Let's Jump right in for it is pretty fascinating...